The opioid epidemic is one of the deadliest problems facing the U.S. today. Through the development of new pain management devices, medtech could be a leader in solving the crisis. The prescription opioid overdose crisis in America didn’t start until the late 1990s, when pharmaceutical companies touted prescription painkillers that weren’t supposed to be addictive. […]
Regenesis Biomedical Inc.
Opioid-related deaths have become an epidemic in the U.S., garnering attention from the White House, the FDA and many other governmental bodies. From 2000 to 2014, nearly half a million Americans died from drug overdoses. In 2015, more than 50,000 people died from drug overdoses, and 33,000 were opioid-related. Prescription overdoses continue to cause more […]
Arizona medical device maker Regenesis Biomedical won new labeling for its Provant Therapy system, removing a contraindication discouraging doctors from using the system on patients with metallic implants in the area of treatment.
The company’s Provant system uses electromagnetic energy to help manage pain and edema in soft tissues following surgery, working by spurring the body’s own pain-relief mechanisms and regulating inflammation responses.
Miramar Labs Inc. raised $35.8 million in a Series C funding round, leaving them just shy of their $36 million goal, according to an SEC filing.
The Sunnyvale, Calif.-based company’s claim to fame is miraDry, a laser-based treatment for excessive underarm sweat. The device uses microwave energy to cook sweat glands in two hour-long noninvasive doctor’s office visits.
The company plans to use the funds to begin marketing the device, according to Xconomy.